Go Pro
NASDAQ:IART

Integra LifeSciences Q3 2026 Earnings Report

Integra LifeSciences logo
$12.68 -3.41 (-21.19%)
Closing price 04:00 PM Eastern
Extended Trading
$12.85 +0.17 (+1.33%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Integra LifeSciences EPS Results

Actual EPS
N/A
Consensus EPS
$0.56
Beat/Miss
N/A
One Year Ago EPS
N/A

Integra LifeSciences Revenue Results

Actual Revenue
N/A
Expected Revenue
$416.30 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Integra LifeSciences Announcement Details

Quarter
Q3 2026
Time
Before Market Opens
Conference Call Date
Thursday, October 29, 2026
Conference Call Time
8:30AM ET

Conference Call Resources

Integra LifeSciences Earnings Headlines

Integra LifeSciences stock tumbles after cutting 2026 outlook
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
Integra LifeSciences plunges 21% on preliminary Q3 results
Integra LifeSciences Launches $600 Million Senior Secured Term Loan B
See More Integra LifeSciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Integra LifeSciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Integra LifeSciences and other key companies, straight to your email.

About Integra LifeSciences

Integra LifeSciences (NASDAQ:IART) (NASDAQ:IART) is a global medical technology company that develops and manufactures products used in neurosurgery, reconstructive surgery, and orthopedic procedures. Its offerings are designed to help physicians treat neurological conditions, traumatic injuries, complex wounds, and other surgical needs.

The company’s products include dural repair and regeneration materials, cerebrospinal fluid management systems, surgical instruments, nerve and tendon repair products, and tissue-engineered solutions for wound care and reconstructive surgery. Integra is also known for its artificial-skin and dermal regeneration products, which are used to support the treatment of burns and other serious wounds.

Founded in 1989, Integra serves hospitals, surgical centers, and healthcare professionals in the United States and international markets. Its business is organized around technologies and products for neurosurgery and reconstructive and orthopedic surgery, with a focus on improving patient outcomes and supporting tissue repair.

View Integra LifeSciences Profile